Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis

Background: The incidence of renal immune-related adverse events (irAEs) is reported to be 3.8%, with varied definitions of acute kidney injury (AKI). This study reports a 10-year experience at MD Anderson Cancer Center of patients diagnosed with melanoma and treated with immune checkpoint inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelrahim, Maen, Mamlouk, Omar, Lin, Heather, Lin, Jamie, Page, Valda, Abdel-Wahab, Noha, Swan, Joshua, Selamet, Umut, Yee, Cassian, Diab, Adi, Suki, Wadi, Abudayyeh, Ala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158025/
https://www.ncbi.nlm.nih.gov/pubmed/34104543
http://dx.doi.org/10.1080/2162402X.2021.1927313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158025/
https://www.ncbi.nlm.nih.gov/pubmed/34104543
http://dx.doi.org/10.1080/2162402X.2021.1927313

Ejemplares similares